ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,180.74
      1.03%
      US Tech 100
      17,584.00
      -0.15%
      Dow Jones
      38,852.27
      0.00%
      Brent Oil
      82.945
      -0.63%
      Bitcoin
      63,499.75
      0.53%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. ARCA Biopharma Inc (ABIO)

      7. ARCA Biopharma Inc (ABIO) News

      ABIO

      ARCA Biopharma (ABIO)

      ARCA Biopharma Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ABIO
      DateTimeSourceHeadlineSymbolCompany
      04/25/20244:15PMGlobeNewswire Inc.ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:ABIOARCA Biopharma Inc
      04/05/20241:09PMPR Newswire (US)Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law FirmNASDAQ:ABIOARCA Biopharma Inc
      04/03/20247:30AMGlobeNewswire Inc.ARCA biopharma and Oruka Therapeutics Announce Merger AgreementNASDAQ:ABIOARCA Biopharma Inc
      04/03/20247:30AMGlobeNewswire Inc.ARCA biopharma and Oruka Therapeutics Announce Merger AgreementNASDAQ:ABIOARCA Biopharma Inc
      02/07/20241:08PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ABIOARCA Biopharma Inc
      02/06/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABIOARCA Biopharma Inc
      02/01/20244:39PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABIOARCA Biopharma Inc
      02/01/20244:35PMGlobeNewswire Inc.ARCA biopharma Announces 2023 Financial ResultsNASDAQ:ABIOARCA Biopharma Inc
      02/01/20244:15PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ABIOARCA Biopharma Inc
      01/31/20246:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
      01/31/20244:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
      01/31/20244:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
      01/31/20244:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
      01/31/20244:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
      01/31/20244:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
      01/31/20244:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
      01/31/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABIOARCA Biopharma Inc
      12/19/20234:25PMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ABIOARCA Biopharma Inc
      12/19/20234:20PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ABIOARCA Biopharma Inc
      12/19/20234:15PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ABIOARCA Biopharma Inc
      12/05/20234:25PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABIOARCA Biopharma Inc
      12/04/20234:36PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABIOARCA Biopharma Inc
      10/18/20234:35PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABIOARCA Biopharma Inc
      10/18/20234:25PMGlobeNewswire Inc.ARCA biopharma Announces Third Quarter 2023 Financial ResultsNASDAQ:ABIOARCA Biopharma Inc
      10/18/20234:15PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ABIOARCA Biopharma Inc
      09/11/20234:01PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ABIOARCA Biopharma Inc
      07/21/20234:35PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABIOARCA Biopharma Inc
      07/21/20234:25PMGlobeNewswire Inc.ARCA biopharma Announces Second Quarter 2023 Financial ResultsNASDAQ:ABIOARCA Biopharma Inc
      07/21/20234:16PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ABIOARCA Biopharma Inc
      04/24/20234:36PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ABIOARCA Biopharma Inc
       Showing the most relevant articles for your search:NASDAQ:ABIO